These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 25270024)
1. CCR7 regulates cell migration and invasion through MAPKs in metastatic squamous cell carcinoma of head and neck. Liu FY; Safdar J; Li ZN; Fang QG; Zhang X; Xu ZF; Sun CF Int J Oncol; 2014 Dec; 45(6):2502-10. PubMed ID: 25270024 [TBL] [Abstract][Full Text] [Related]
2. CCR7 regulates cell migration and invasion through JAK2/STAT3 in metastatic squamous cell carcinoma of the head and neck. Liu FY; Safdar J; Li ZN; Fang QG; Zhang X; Xu ZF; Sun CF Biomed Res Int; 2014; 2014():415375. PubMed ID: 25405202 [TBL] [Abstract][Full Text] [Related]
3. CCL19-induced chemokine receptor 7 activates the phosphoinositide-3 kinase-mediated invasive pathway through Cdc42 in metastatic squamous cell carcinoma of the head and neck. Zhao ZJ; Liu FY; Li P; Ding X; Zong ZH; Sun CF Oncol Rep; 2011 Mar; 25(3):729-37. PubMed ID: 21165582 [TBL] [Abstract][Full Text] [Related]
4. The role of Pyk2 in the CCR7-mediated regulation of metastasis and viability in squamous cell carcinoma of the head and neck cells in vivo and in vitro. Yue Y; Li ZN; Fang QG; Zhang X; Yang LL; Sun CF; Liu FY Oncol Rep; 2015 Dec; 34(6):3280-7. PubMed ID: 26352169 [TBL] [Abstract][Full Text] [Related]
5. Chemokine receptor 7 promotes tumor migration and invasiveness via the RhoA/ROCK pathway in metastatic squamous cell carcinoma of the head and neck. Xu Z; Zheng X; Yang L; Liu F; Zhang E; Duan W; Bai S; Safdar J; Li Z; Sun C Oncol Rep; 2015 Feb; 33(2):849-55. PubMed ID: 25434638 [TBL] [Abstract][Full Text] [Related]
6. Chemokine receptor 7 promotes cell migration and adhesion in metastatic squamous cell carcinoma of the head and neck by activating integrin αvβ3. Li P; Liu F; Sun L; Zhao Z; Ding X; Shang D; Xu Z; Sun C Int J Mol Med; 2011 May; 27(5):679-87. PubMed ID: 21347514 [TBL] [Abstract][Full Text] [Related]
7. Chemokine receptor 7 enhances cell chemotaxis and migration of metastatic squamous cell carcinoma of head and neck through activation of matrix metalloproteinase-9. Guo N; Liu F; Yang L; Huang J; Ding X; Sun C Oncol Rep; 2014 Aug; 32(2):794-800. PubMed ID: 24912620 [TBL] [Abstract][Full Text] [Related]
8. MiR-1275 promotes cell migration, invasion and proliferation in squamous cell carcinoma of head and neck via up-regulating IGF-1R and CCR7. Liu MD; Wu H; Wang S; Pang P; Jin S; Sun CF; Liu FY Gene; 2018 Mar; 646():1-7. PubMed ID: 29278769 [TBL] [Abstract][Full Text] [Related]
9. Chemokine receptor 7 via proline-rich tyrosine kinase-2 upregulates the chemotaxis and migration ability of squamous cell carcinoma of the head and neck. Yang L; Liu F; Xu Z; Guo N; Zheng X; Sun C Oncol Rep; 2012 Nov; 28(5):1659-64. PubMed ID: 22923218 [TBL] [Abstract][Full Text] [Related]
10. Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy. Wang J; Seethala RR; Zhang Q; Gooding W; van Waes C; Hasegawa H; Ferris RL J Natl Cancer Inst; 2008 Apr; 100(7):502-12. PubMed ID: 18364504 [TBL] [Abstract][Full Text] [Related]
11. CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1. Shi M; Chen D; Yang D; Liu XY J Exp Clin Cancer Res; 2015 Dec; 34():149. PubMed ID: 26667143 [TBL] [Abstract][Full Text] [Related]
12. The chemokine receptor 7 regulates cell adhesion and migration via beta1 integrin in metastatic squamous cell carcinoma of the head and neck. Li P; Zhao ZJ; Liu FY; Sun LY; Ding X; Zhang WZ; Shang DH; Sun CF Oncol Rep; 2010 Oct; 24(4):989-95. PubMed ID: 20811680 [TBL] [Abstract][Full Text] [Related]
13. NF-κB participates in chemokine receptor 7-mediated cell survival in metastatic squamous cell carcinoma of the head and neck. Liu FY; Zhao ZJ; Li P; Ding X; Guo N; Yang LL; Zong ZH; Sun CF Oncol Rep; 2011 Feb; 25(2):383-91. PubMed ID: 21165563 [TBL] [Abstract][Full Text] [Related]
14. CCR7 mediates the TNF-α-induced lymphatic metastasis of gallbladder cancer through the "ERK1/2 - AP-1" and "JNK - AP-1" pathways. Hong H; He C; Zhu S; Zhang Y; Wang X; She F; Chen Y J Exp Clin Cancer Res; 2016 Mar; 35():51. PubMed ID: 27009073 [TBL] [Abstract][Full Text] [Related]
15. CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer. Xiong Y; Huang F; Li X; Chen Z; Feng D; Jiang H; Chen W; Zhang X Int J Oncol; 2017 Jul; 51(1):75-90. PubMed ID: 28534984 [TBL] [Abstract][Full Text] [Related]
16. Chemokine receptor 7 (CCR7) gene expression is regulated by NF-κB and activator protein 1 (AP1) in metastatic squamous cell carcinoma of head and neck (SCCHN). Mburu YK; Egloff AM; Walker WH; Wang L; Seethala RR; van Waes C; Ferris RL J Biol Chem; 2012 Jan; 287(5):3581-90. PubMed ID: 22158872 [TBL] [Abstract][Full Text] [Related]
17. Overexpressed HGF promotes metastasis of squamous cell carcinoma of the head and neck through the PI3K/Akt and JNK signaling pathways. Guo N; Liang J; Gao X; Yang X; Fan X; Zhao Y Future Oncol; 2021 Nov; 17(33):4527-4543. PubMed ID: 34435890 [No Abstract] [Full Text] [Related]
18. Jak3 is involved in CCR7-dependent migration and invasion in metastatic squamous cell carcinoma of the head and neck. Zhang Z; Liu F; Li Z; Wang D; Li R; Sun C Oncol Lett; 2017 May; 13(5):3191-3197. PubMed ID: 28521425 [TBL] [Abstract][Full Text] [Related]
19. Human β-defensin 3 promotes NF-κB-mediated CCR7 expression and anti-apoptotic signals in squamous cell carcinoma of the head and neck. Mburu YK; Abe K; Ferris LK; Sarkar SN; Ferris RL Carcinogenesis; 2011 Feb; 32(2):168-74. PubMed ID: 21071608 [TBL] [Abstract][Full Text] [Related]
20. Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway. Zhong G; Chen L; Yin R; Qu Y; Bao Y; Xiao Q; Zhang Z; Shen Y; Li C; Xu Y; Zou Z; Tian H Mol Med Rep; 2017 Jun; 15(6):4100-4108. PubMed ID: 28487957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]